VEJA TAMBÉM
Activating Enhancer-Binding Protein Anticorpos
Empty Table Header | Nome do Produto | CATALOG # | Isótopo | Epitopo | Aplicacao | Species | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|---|
AP-2α Anticorpo (3B5) | sc-12726 | mouse IgG2b κ | N-Terminal (h) | WB, IP, IF, IHC(P) | m, r, h | 100 | ||
AP-2α Anticorpo (D-12) | sc-25343 | mouse IgG1 κ | 130-209 (h) | WB, IP, IF, ELISA | m, r, h | 11 | ||
AP-2α Anticorpo (G8/5) | sc-53164 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h | 1 | ||
AP-2α Anticorpo (B-11) | sc-55485 | mouse IgG1 κ | 130-209 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | new | ||
AP-2α/β Anticorpo (A6/2/2) | sc-53163 | mouse IgG1 κ | C-Terminal (h) | WB, IP, IF, IHC(P), FCM | m, r, h | 1 | ||
AP-2α/β Anticorpo (3H547) | sc-70361 | mouse IgG1 κ | C-Terminal (h) | WB, IP, IF, IHC(P), FCM | m, r, h | 1 | ||
AP-2β Anticorpo (C-6) | sc-390119 | mouse IgG1 κ | 130-216 (h) | WB, IP, IF, ELISA | m, r, h | 5 | ||
AP-2β Anticorpo (1F3/8) | sc-53160 | mouse IgG2a κ | (h) | WB, IP | m, r, h | new | ||
AP-2β Anticorpo (1G6/2) | sc-53161 | mouse IgG2b κ | (h) | WB, IP | m, r, h | new | ||
AP-2β Anticorpo (A-1) | sc-166441 | mouse IgG1 κ | 128-159 (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
AP-2β Anticorpo (E-8) | sc-390281 | mouse IgG1 κ | 149-187 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 2 | ||
AP-2β Anticorpo (G-7) | sc-390135 | mouse IgM κ | 130-216 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
AP-2γ Anticorpo (6E4/4) | sc-12762 | mouse IgG1 κ | C-Terminal (h) | WB, IP, IF, IHC(P) | m, r, h | 146 | ||
AP-2γ Anticorpo (AP2g 6E4/4) | sc-53162 | mouse IgG1 κ | (h) | WB, IP, IF, IHC(P) | m, r, h | 5 | ||
AP-2γ Anticorpo (B-9) | sc-377458 | mouse IgG1 κ | 183-219 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
AP-4 Anticorpo (A-8) | sc-377042 | mouse IgG2a κ | 93-176 (h) | WB, IP, IF, ELISA | m, r, h | 5 | ||
AP-4 Anticorpo (B-3) | sc-166024 | mouse IgG1 κ | 2-43 (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
AP-4 Anticorpo (F-1) | sc-376977 | mouse IgG1 κ | 93-176 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
AP-4 Anticorpo (H-5) | sc-166216 | mouse IgG1 κ | 2-43 (h) | WB, IP, IF, ELISA | m, r, h | 1 |
Activating Enhancer-Binding Protein CRISPR Knockout, HDR and Double Nickase Plasmids
Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
AP-2α Plasmídeo CRISPR/Cas9 KO (h) | sc-400935 | h | Gene Knockout | GFP | 0 | ||
AP-2αPlasmídeo HDR (h) | sc-400935-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AP-2α Plasmídeo duplo de Nickase (h) | sc-400935-NIC | h | Gene Knockout | Puromycin | 0 | ||
AP-2α Plasmídeo duplo de Nickase (h2) | sc-400935-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
AP-2β Plasmídeo CRISPR/Cas9 KO (h) | sc-401846 | h | Gene Knockout | GFP | 0 | ||
AP-2βPlasmídeo HDR (h) | sc-401846-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AP-2β Plasmídeo duplo de Nickase (h) | sc-401846-NIC | h | Gene Knockout | Puromycin | 0 | ||
AP-2β Plasmídeo duplo de Nickase (h2) | sc-401846-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
AP-2δ Plasmídeo CRISPR/Cas9 KO (h) | sc-413501 | h | Gene Knockout | GFP | 0 | ||
AP-2δPlasmídeo HDR (h) | sc-413501-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AP-2δ Plasmídeo duplo de Nickase (h) | sc-413501-NIC | h | Gene Knockout | Puromycin | 0 | ||
AP-2δ Plasmídeo duplo de Nickase (h2) | sc-413501-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
AP-2ε Plasmídeo CRISPR/Cas9 KO (h) | sc-415518 | h | Gene Knockout | GFP | 0 | ||
AP-2εPlasmídeo HDR (h) | sc-415518-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AP-2ε Plasmídeo duplo de Nickase (h) | sc-415518-NIC | h | Gene Knockout | Puromycin | 0 | ||
AP-2ε Plasmídeo duplo de Nickase (h2) | sc-415518-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
AP-2γ Plasmídeo CRISPR/Cas9 KO (h) | sc-400884 | h | Gene Knockout | GFP | 0 | ||
AP-2γPlasmídeo HDR (h) | sc-400884-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AP-2γ Plasmídeo duplo de Nickase (h) | sc-400884-NIC | h | Gene Knockout | Puromycin | 0 | ||
AP-2γ Plasmídeo duplo de Nickase (h2) | sc-400884-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
AP-4 Plasmídeo CRISPR/Cas9 KO (h) | sc-404336 | h | Gene Knockout | GFP | 0 | ||
AP-4Plasmídeo HDR (h) | sc-404336-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AP-4 Plasmídeo duplo de Nickase (h) | sc-404336-NIC | h | Gene Knockout | Puromycin | 0 | ||
AP-4 Plasmídeo duplo de Nickase (h2) | sc-404336-NIC-2 | h | Gene Knockout | Puromycin | 0 |
Activating Enhancer-Binding Protein CRISPR Activation Products
Activating Enhancer-Binding Protein siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
Empty Table Header | Nome do Produto | CATALOG # | Species | Aplicacao | MARCADOR | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|---|
AP-2α siRNA (h) | sc-105074 | h | Gene Silencing | N/A | 4 | ||
AP-2α Plasmídeo shRNA (h) | sc-105074-SH | h | Gene Silencing | Puromycin | 4 | ||
AP-2α sarna (h) Partículas de lentivirus | sc-105074-V | h | Gene Silencing | Puromycin | 4 | ||
AP-2α siRNA (m) | sc-29697 | m | Gene Silencing | N/A | 2 | ||
AP-2α Plasmídeo shRNA (m) | sc-29697-SH | m | Gene Silencing | Puromycin | 2 | ||
AP-2α sarna (m) Partículas de lentivirus | sc-29697-V | m | Gene Silencing | Puromycin | 2 | ||
AP-2β siRNA (h) | sc-37687 | h | Gene Silencing | N/A | 2 | ||
AP-2β Plasmídeo shRNA (h) | sc-37687-SH | h | Gene Silencing | Puromycin | 2 | ||
AP-2β sarna (h) Partículas de lentivirus | sc-37687-V | h | Gene Silencing | Puromycin | 2 | ||
AP-2β siRNA (m) | sc-37688 | m | Gene Silencing | N/A | 0 | ||
AP-2β Plasmídeo shRNA (m) | sc-37688-SH | m | Gene Silencing | Puromycin | 0 | ||
AP-2β sarna (m) Partículas de lentivirus | sc-37688-V | m | Gene Silencing | Puromycin | 0 | ||
AP-2δ siRNA (h) | sc-95077 | h | Gene Silencing | N/A | 0 | ||
AP-2δ Plasmídeo shRNA (h) | sc-95077-SH | h | Gene Silencing | Puromycin | 0 | ||
AP-2δ sarna (h) Partículas de lentivirus | sc-95077-V | h | Gene Silencing | Puromycin | 0 | ||
AP-2δ siRNA (m) | sc-141133 | m | Gene Silencing | N/A | 0 | ||
AP-2δ Plasmídeo shRNA (m) | sc-141133-SH | m | Gene Silencing | Puromycin | 0 | ||
AP-2δ sarna (m) Partículas de lentivirus | sc-141133-V | m | Gene Silencing | Puromycin | 0 | ||
AP-2ε siRNA (h) | sc-88389 | h | Gene Silencing | N/A | 0 | ||
AP-2ε Plasmídeo shRNA (h) | sc-88389-SH | h | Gene Silencing | Puromycin | 0 | ||
AP-2ε sarna (h) Partículas de lentivirus | sc-88389-V | h | Gene Silencing | Puromycin | 0 | ||
AP-2ε siRNA (m) | sc-141134 | m | Gene Silencing | N/A | 0 | ||
AP-2ε Plasmídeo shRNA (m) | sc-141134-SH | m | Gene Silencing | Puromycin | 0 | ||
AP-2ε sarna (m) Partículas de lentivirus | sc-141134-V | m | Gene Silencing | Puromycin | 0 | ||
AP-2γ siRNA (h) | sc-29696 | h | Gene Silencing | N/A | 3 | ||
AP-2γ Plasmídeo shRNA (h) | sc-29696-SH | h | Gene Silencing | Puromycin | 3 | ||
AP-2γ sarna (h) Partículas de lentivirus | sc-29696-V | h | Gene Silencing | Puromycin | 3 | ||
AP-2γ siRNA (m) | sc-37689 | m | Gene Silencing | N/A | 0 | ||
AP-2γ Plasmídeo shRNA (m) | sc-37689-SH | m | Gene Silencing | Puromycin | 0 | ||
AP-2γ sarna (m) Partículas de lentivirus | sc-37689-V | m | Gene Silencing | Puromycin | 0 | ||
AP-4 siRNA (h) | sc-37690 | h | Gene Silencing | N/A | 2 | ||
AP-4 Plasmídeo shRNA (h) | sc-37690-SH | h | Gene Silencing | Puromycin | 2 | ||
AP-4 sarna (h) Partículas de lentivirus | sc-37690-V | h | Gene Silencing | Puromycin | 2 | ||
AP-4 siRNA (m) | sc-37691 | m | Gene Silencing | N/A | 0 | ||
AP-4 Plasmídeo shRNA (m) | sc-37691-SH | m | Gene Silencing | Puromycin | 0 | ||
AP-4 sarna (m) Partículas de lentivirus | sc-37691-V | m | Gene Silencing | Puromycin | 0 |